CBLL

CeriBell, Inc. (CBLL)
Healthcare • Medical Devices • $17.69 • MCap: 671,206,400 🌐
https://www.ceribell.com • CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Buy Decision Core
Total Score
46
Business Quality
10
Financial Strength
15
Growth Outlook
1
Momentum
3
Price Action
Current
17.69
52W High
23.43
52W Low
10.92
Above 50DMA
18.53 (-4.52%)
Above 200DMA
18.48 (-4.26%)
Relative Strength
Relative Strength
0.03
RS 3M
-0.12
RS 6M
-0.13
RS 9M
0.38
RS 12M
0.16
Fundamentals
Revenue Growth
0.29%
Earnings Growth
0%
ROE
-0.38%
ROA
-0.21%
Valuation
PE (Fwd)
-16.11
PEG
0
P/B
4.76
Upside
51.82%
Risk
Beta
0
Short %
0.08
Risk Score
7.00
Analyst
Rating
none
Target
26.86
Beta
0
Analysts
0


Total Score
46
Upside
51.82%
Relative Strength
0.03
Beta
0
Why Buy?
  • PEG Ratio below 1 (attractive valuation)
  • Analyst upside exceeds 15%
Key Risks
  • Negative ROE
Score Breakdown
Business
10
Financial
15
Growth
1
Valuation
10
Risk
3
Momentum
3
Technical
52W High: 23.43
52W Low: 10.92
Above 50DMA: -4.52%
Above 200DMA: -4.26%
Valuation
Forward PE: -16.11
PEG: 0
P/B: 4.76
Upside: 51.82%
Risk
Beta: 0
Short Float: 0.08%
ROE: -0.38%
ROA: -0.21%